Annual SG&A
$6.64 M
-$1.57 M-19.09%
31 March 2024
Summary:
Acasti Pharma annual selling, general & administrative expenses is currently $6.64 million, with the most recent change of -$1.57 million (-19.09%) on 31 March 2024. During the last 3 years, it has fallen by -$11.00 thousand (-0.17%). ACST annual SG&A is now -32.07% below its all-time high of $9.78 million, reached on 31 March 2022.ACST Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.85 M
-$401.00 K-17.79%
30 September 2024
Summary:
Acasti Pharma quarterly selling, general & administrative expenses is currently $1.85 million, with the most recent change of -$401.00 thousand (-17.79%) on 30 September 2024. Over the past year, it has increased by +$222.00 thousand (+13.61%). ACST quarterly SG&A is now -37.86% below its all-time high of $2.98 million, reached on 30 September 2021.ACST Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$849.98 M
-$11.61 M-1.38%
30 September 2024
Summary:
Acasti Pharma TTM selling, general & administrative expenses is currently -$849.98 million, with the most recent change of -$11.61 million (-1.38%) on 30 September 2024. Over the past year, it has dropped by -$857.77 million (-11006.92%). ACST TTM SG&A is now -7959.01% below its all-time high of $9.78 million, reached on 31 March 2022.ACST TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACST Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.1% | +13.6% | -10000.0% |
| 3 y3 years | -0.2% | -37.9% | -10000.0% |
| 5 y5 years | +54.8% | -19.5% | -10000.0% |
ACST Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -32.1% | at low | -37.9% | +20.1% | -45.6% | at low |
| 5 y | 5 years | -32.1% | +54.8% | -37.9% | +39.2% | -109.0% | at low |
| alltime | all time | -32.1% | +1526.0% | -37.9% | +253.0% | -7959.0% | at low |
Acasti Pharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.85 M(-17.8%) | $7.25 M(+3.2%) |
| June 2024 | - | $2.25 M(+46.1%) | $7.03 M(+5.8%) |
| Mar 2024 | $6.64 M(-19.1%) | $1.54 M(-3.6%) | $6.64 M(-12.8%) |
| Dec 2023 | - | $1.60 M(-1.9%) | $7.62 M(-2.2%) |
| Sept 2023 | - | $1.63 M(-12.8%) | $7.79 M(-2.5%) |
| June 2023 | - | $1.87 M(-25.6%) | $7.99 M(-2.7%) |
| Mar 2023 | $8.21 M(-16.0%) | $2.52 M(+41.7%) | $8.21 M(+5.6%) |
| Dec 2022 | - | $1.77 M(-2.9%) | $7.77 M(-3.4%) |
| Sept 2022 | - | $1.83 M(-12.7%) | $8.04 M(-12.5%) |
| June 2022 | - | $2.09 M(+0.8%) | $9.20 M(-6.0%) |
| Mar 2022 | $9.78 M(+47.0%) | $2.08 M(+1.5%) | $9.78 M(+6.2%) |
| Dec 2021 | - | $2.05 M(-31.4%) | $9.21 M(+8.4%) |
| Sept 2021 | - | $2.98 M(+11.4%) | $8.50 M(+21.9%) |
| June 2021 | - | $2.68 M(+77.3%) | $6.97 M(+4.7%) |
| Mar 2021 | $6.66 M(-21.4%) | $1.51 M(+13.4%) | $6.66 M(-8.3%) |
| Dec 2020 | - | $1.33 M(-8.4%) | $7.26 M(-11.1%) |
| Sept 2020 | - | $1.45 M(-38.6%) | $8.16 M(-9.4%) |
| June 2020 | - | $2.37 M(+11.9%) | $9.01 M(+6.5%) |
| Mar 2020 | $8.46 M(+97.2%) | $2.11 M(-5.4%) | $8.46 M(+4.8%) |
| Dec 2019 | - | $2.23 M(-2.9%) | $8.07 M(+20.7%) |
| Sept 2019 | - | $2.30 M(+26.7%) | $6.69 M(+23.8%) |
| June 2019 | - | $1.82 M(+5.4%) | $5.40 M(+23.5%) |
| Mar 2019 | $4.29 M(+37.6%) | $1.72 M(+103.3%) | $4.37 M(+21.2%) |
| Dec 2018 | - | $847.30 K(-16.4%) | $3.61 M(+4.6%) |
| Sept 2018 | - | $1.01 M(+28.7%) | $3.45 M(+5.5%) |
| June 2018 | - | $787.70 K(-17.7%) | $3.27 M(+5.1%) |
| Mar 2018 | $3.12 M(+16.9%) | $956.90 K(+39.1%) | $3.11 M(+44.5%) |
| Dec 2017 | - | $687.90 K(-17.6%) | $2.15 M(+3.4%) |
| Sept 2017 | - | $835.10 K(+32.9%) | $2.08 M(+9.5%) |
| June 2017 | - | $628.20 K(+1.8%) | $1.90 M(-5.4%) |
| Mar 2017 | $2.67 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2016 | - | $617.00 K(-5.6%) | $2.01 M(+14.7%) |
| Aug 2016 | - | $653.90 K(+50.7%) | $1.75 M(+18.6%) |
| May 2016 | - | $434.00 K(+43.7%) | $1.48 M(-4.8%) |
| Feb 2016 | $1.51 M(-47.1%) | $302.00 K(-16.0%) | $1.55 M(+4156.3%) |
| Nov 2015 | - | $359.70 K(-5.2%) | $36.40 K(-95.1%) |
| Aug 2015 | - | $379.60 K(-25.3%) | $742.60 K(-60.6%) |
| May 2015 | - | $508.00 K(-142.0%) | $1.89 M(-37.6%) |
| Feb 2015 | $2.86 M(-35.8%) | -$1.21 M(-213.6%) | $3.02 M(-22.1%) |
| Nov 2014 | - | $1.07 M(-30.0%) | $3.88 M(-18.2%) |
| Aug 2014 | - | $1.52 M(-7.3%) | $4.74 M(-4.6%) |
| May 2014 | - | $1.64 M(-564.4%) | $4.97 M(+10.6%) |
| Feb 2014 | $4.45 M(+6.2%) | -$353.60 K(-118.3%) | $4.49 M(-22.7%) |
| Nov 2013 | - | $1.93 M(+10.0%) | $5.81 M(+17.9%) |
| Aug 2013 | - | $1.75 M(+50.1%) | $4.93 M(+15.2%) |
| May 2013 | - | $1.17 M(+20.9%) | $4.28 M(+3.1%) |
| Feb 2013 | $4.19 M(+18.0%) | $965.80 K(-7.7%) | $4.15 M(-6.8%) |
| Nov 2012 | - | $1.05 M(-5.1%) | $4.45 M(+5.3%) |
| Aug 2012 | - | $1.10 M(+6.2%) | $4.23 M(+5.7%) |
| May 2012 | - | $1.04 M(-18.3%) | $4.00 M(+10.5%) |
| Feb 2012 | $3.55 M(+115.8%) | $1.27 M(+54.1%) | $3.62 M(+22.7%) |
| Nov 2011 | - | $823.50 K(-5.7%) | $2.95 M(+15.6%) |
| Aug 2011 | - | $873.60 K(+33.2%) | $2.55 M(+27.7%) |
| May 2011 | - | $655.90 K(+9.6%) | $2.00 M(+23.3%) |
| Feb 2011 | $1.64 M(+302.6%) | $598.30 K(+40.8%) | $1.62 M(+38.5%) |
| Nov 2010 | - | $424.80 K(+32.5%) | $1.17 M(+38.8%) |
| Aug 2010 | - | $320.50 K(+15.0%) | $843.80 K(+35.9%) |
| May 2010 | - | $278.70 K(+89.6%) | $620.80 K(+53.9%) |
| Feb 2010 | $408.60 K | $147.00 K(+50.6%) | $403.30 K(+57.4%) |
| Nov 2009 | - | $97.60 K(+0.1%) | $256.30 K(+0.3%) |
| Aug 2009 | - | $97.50 K(+59.3%) | $255.60 K(+61.7%) |
| May 2009 | - | $61.20 K(-36.8%) | $158.10 K(+63.2%) |
| Nov 2008 | - | $96.90 K | $96.90 K |
FAQ
- What is Acasti Pharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Acasti Pharma?
- What is Acasti Pharma annual SG&A year-on-year change?
- What is Acasti Pharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Acasti Pharma?
- What is Acasti Pharma quarterly SG&A year-on-year change?
- What is Acasti Pharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Acasti Pharma?
- What is Acasti Pharma TTM SG&A year-on-year change?
What is Acasti Pharma annual selling, general & administrative expenses?
The current annual SG&A of ACST is $6.64 M
What is the all time high annual SG&A for Acasti Pharma?
Acasti Pharma all-time high annual selling, general & administrative expenses is $9.78 M
What is Acasti Pharma annual SG&A year-on-year change?
Over the past year, ACST annual selling, general & administrative expenses has changed by -$1.57 M (-19.09%)
What is Acasti Pharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of ACST is $1.85 M
What is the all time high quarterly SG&A for Acasti Pharma?
Acasti Pharma all-time high quarterly selling, general & administrative expenses is $2.98 M
What is Acasti Pharma quarterly SG&A year-on-year change?
Over the past year, ACST quarterly selling, general & administrative expenses has changed by +$222.00 K (+13.61%)
What is Acasti Pharma TTM selling, general & administrative expenses?
The current TTM SG&A of ACST is -$849.98 M
What is the all time high TTM SG&A for Acasti Pharma?
Acasti Pharma all-time high TTM selling, general & administrative expenses is $9.78 M
What is Acasti Pharma TTM SG&A year-on-year change?
Over the past year, ACST TTM selling, general & administrative expenses has changed by -$857.77 M (-11006.92%)